GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shaperon Inc (XKRX:378800) » Definitions » Total Equity

Shaperon (XKRX:378800) Total Equity : ₩19,575.51 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shaperon Total Equity?

Shaperon's total equity for the quarter that ended in Sep. 2024 was ₩19,575.51 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Shaperon Total Equity Historical Data

The historical data trend for Shaperon's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shaperon Total Equity Chart

Shaperon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
-26,848.43 -52,993.45 24,399.43 29,279.78 18,996.11

Shaperon Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23,520.74 18,996.11 14,073.17 22,868.87 19,575.51

Shaperon Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shaperon's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=25008.602-6012.497
=18,996.11

Shaperon's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=24314.692-4739.178
=19,575.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shaperon Total Equity Related Terms

Thank you for viewing the detailed overview of Shaperon's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shaperon Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shaperon Inc (XKRX:378800) » Definitions » Total Equity
Comparable Companies
XKRX:388870 XKRX:049960 XKRX:348150 XKRX:203690 XKRX:284620 XKRX:299660 XKRX:217730 XKRX:067370 XKRX:338840 XKRX:321550 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
Gangnam Ace Tower G9, Suie 218 & 606, 174-10 Jagok-ro, Gangnam-gu, Seoul, KOR, 06373
Website
http://www.shaperon.com
Shaperon Inc is a developer of innovative inflammasome inhibitors and nanobody therapeutics intended to develop novel treatments for various chronic inflammatory diseases, including atopic dermatitis, systemic inflammatory response syndrome, neuroinflammatory diseases, and chronic inflammation. It offers a range of drug candidates, including a gel-type atopic dermatitis drug for use in the treatment of systemic inflammatory response syndrome, neuroinflammatory diseases and for treating chronic inflammation. The company also provides immunotherapeutic products and a single-domain neutralizing antibody, enabling clients to improve patient's quality of life by developing safe and efficacious drugs and immunotherapies.

Shaperon Headlines

No Headlines